Gland Pharma Approves ₹20 Dividend, Subject to Shareholder Approval

Gland Pharma Ltd's Board of Directors has approved a final dividend of ₹20 per equity share (2000% on face value of ₹1) for the financial year 2025-26, subject to shareholder approval at the 48th Annual General Meeting (AGM). The dividend will be paid within 30 days of AGM approval. The record date for determining eligibility for the dividend is set for August 11, 2026. The 48th AGM will be held via video conferencing on August 25, 2026.